Skip to main content
Clinical Trials/NL-OMON24018
NL-OMON24018Not yet recruitingNot Applicable

Effects of GLP1 agonist liRAglutiDE in patients with antispychotic-drUgs-associATEd diabetes mellitus

MC Utrecht0 sites50 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
50

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Informed consent obtained before any trial related activities
  • Males or females aged 18 years or older

Exclusion Criteria

  • Any type of diabetes present before the use of anti-psychotic drugs
  • Use of glucose-lowering medication other than metformin

Investigators

Sponsor
MC Utrecht

Similar Trials